Latest Breaking News On - போரிஸ் உச்சம் - Page 1 : comparemela.com
CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
ImmunoGen, inc (IMGN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Operator
Good morning, and welcome to the ImmunoGen s First Quarter of 2021 Financial and Operating Results Conference Call. Today s conference is being recorded. At this time, I d like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Ma am, please go ahead.
Courtney O Konek
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress in first quarter 2021 financial results. This press release and a recording of this call can be found under the Investors & Media section of our website at immunogen.com.
Operator
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I will now turn the call over to your host, Malin Deon with Jounce Therapeutics. Please go ahead.
Malin Deon
Manager, Investor Relations & Corporate Communications
Thank you, operator. Good morning, and welcome to the Jounce Therapeutics first quarter conference call. This morning we issued a press release which outlines the topics that we plan to discuss today. The release is available in the Investors and Media section of our website at www.jouncetx.com.
Speaking on today s call will be our CEO and President, Dr. Rich Murray, who will review our pipeline progress, and key milestones, followed by our CSO, Dr. Dmitri Wiederschain, who will discuss our discovery efforts. Our CMO, Dr. Beth Trehu will then provide an update on our clinical activities, and lastly, our CFO, Kim Drapkin will review our first quarter financial resu
MacroGenics (MGNX) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble.
MacroGenics (NASDAQ: MGNX)
Good afternoon, we will begin the MacroGenics 2021 first-quarter corporate progress and financial results conference call in just a moment. All participants are in listen-only mode at the moment, and we will conduct a question-and-answer session at the conclusion of the call. At this point, I will turn the call over to Jim Karrels, senior vice president, chief financial officer of MacroGenics.
Jim Karrels
Senior Vice President, Chief Financial Officer, and Treasurer
Thank you, operator. Good afternoon and welcome to MacroGenics ss conference call to discuss our first-quarter 2021 financial and operational results. For anyone who has not had the chance to review these results, we issued a press release this afternoon, outlining today s announcements, which is available under the Investors tab
vimarsana © 2020. All Rights Reserved.